| Patrick Grace, MD | |
|
1000 S Limestone, Lexington, KY 40536-1793 | |
| (859) 323-5901 | |
| Not Available |
| Full Name | Patrick Grace |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 1000 S Limestone, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083145569 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kentucky Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Current recommendations for weight gain during pregnancy - developed by the Institute of Medicine (IOM) in 1990 - should be revised, according to an internationally recognized obesity expert and chairman of obstetrics, gynecology and women's health at Saint Louis University.
A multinational study has found that 5 to 6 percent of patients in intensive care units experience acute kidney failure, and about 60 percent of these patients die in the hospital, according to an article in the August 17 issue of JAMA: The Journal of the American Medical Association.
HIV prevention services will be combined with access to gender-affirming hormonal therapy and peer health navigation to try to reduce the disproportionate percentage of transgender women who are HIV positive in an innovative study led by researchers at The University of Texas Health Science Center at Houston (UTHeath).
› Verified 9 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Current recommendations for weight gain during pregnancy - developed by the Institute of Medicine (IOM) in 1990 - should be revised, according to an internationally recognized obesity expert and chairman of obstetrics, gynecology and women's health at Saint Louis University.
A multinational study has found that 5 to 6 percent of patients in intensive care units experience acute kidney failure, and about 60 percent of these patients die in the hospital, according to an article in the August 17 issue of JAMA: The Journal of the American Medical Association.
HIV prevention services will be combined with access to gender-affirming hormonal therapy and peer health navigation to try to reduce the disproportionate percentage of transgender women who are HIV positive in an innovative study led by researchers at The University of Texas Health Science Center at Houston (UTHeath).
› Verified 9 days ago
| Entity Name | Ich-epg Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679005557 PECOS PAC ID: 5092092577 Enrollment ID: O20170510002374 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Current recommendations for weight gain during pregnancy - developed by the Institute of Medicine (IOM) in 1990 - should be revised, according to an internationally recognized obesity expert and chairman of obstetrics, gynecology and women's health at Saint Louis University.
A multinational study has found that 5 to 6 percent of patients in intensive care units experience acute kidney failure, and about 60 percent of these patients die in the hospital, according to an article in the August 17 issue of JAMA: The Journal of the American Medical Association.
HIV prevention services will be combined with access to gender-affirming hormonal therapy and peer health navigation to try to reduce the disproportionate percentage of transgender women who are HIV positive in an innovative study led by researchers at The University of Texas Health Science Center at Houston (UTHeath).
› Verified 9 days ago
| Entity Name | Empact Midwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841801784 PECOS PAC ID: 9436577517 Enrollment ID: O20200922002897 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Current recommendations for weight gain during pregnancy - developed by the Institute of Medicine (IOM) in 1990 - should be revised, according to an internationally recognized obesity expert and chairman of obstetrics, gynecology and women's health at Saint Louis University.
A multinational study has found that 5 to 6 percent of patients in intensive care units experience acute kidney failure, and about 60 percent of these patients die in the hospital, according to an article in the August 17 issue of JAMA: The Journal of the American Medical Association.
HIV prevention services will be combined with access to gender-affirming hormonal therapy and peer health navigation to try to reduce the disproportionate percentage of transgender women who are HIV positive in an innovative study led by researchers at The University of Texas Health Science Center at Houston (UTHeath).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Grace, MD 800 Rose St, Room M-53, Lexington, KY 40536-0293 Ph: (859) 323-2300 | Patrick Grace, MD 1000 S Limestone, Lexington, KY 40536-1793 Ph: (859) 323-5901 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Current recommendations for weight gain during pregnancy - developed by the Institute of Medicine (IOM) in 1990 - should be revised, according to an internationally recognized obesity expert and chairman of obstetrics, gynecology and women's health at Saint Louis University.
A multinational study has found that 5 to 6 percent of patients in intensive care units experience acute kidney failure, and about 60 percent of these patients die in the hospital, according to an article in the August 17 issue of JAMA: The Journal of the American Medical Association.
HIV prevention services will be combined with access to gender-affirming hormonal therapy and peer health navigation to try to reduce the disproportionate percentage of transgender women who are HIV positive in an innovative study led by researchers at The University of Texas Health Science Center at Houston (UTHeath).
› Verified 9 days ago
Mikalah Andree Ward, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Rose St Rm M-53, Lexington, KY 40536 Phone: 859-323-5083 | |
Allison Woodall, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky And Affiliates, 800 Rose St., Lexington, KY 40536 Phone: 859-323-5871 | |
Traci Westerfield, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2416 Regency Road, Lexington, KY 40503 Phone: 859-278-1316 Fax: 859-276-1574 | |
Dr. Hollis R Hilty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1740 Nicholasville Road, Lexington, KY 40503 Phone: 859-260-6180 Fax: 859-260-6693 | |
James Byron Moore Ii, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3205 Summit Square Pl Ste 100, Lexington, KY 40509 Phone: 859-335-9041 Fax: 859-335-9072 | |
Dr. Matthew Stewart Dawson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 230 W Main St, Lexington, KY 40507 Phone: 859-309-4839 | |
Dr. Jeremiah Phelps, MD PHD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky, 800 Rose St, Lexington, KY 40536 Phone: 859-323-6762 |